In situ telomerase activity in pancreatic juice may discriminate pancreatic cancer from other pancreatic diseases

Pancreas

Volumn 36, Issue 3, 2008, Pages 236-240

  Uehara, Hiroyuki ^a   Nakaizumi, Akihiko ^a   Iishi, Hiroyasu ^a   Takenaka, Akemi ^a   Eguchi, Hidetoshi ^a   Ohigashi, Hiroaki ^a   Ishikawa, Osamu ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

In situ; Pancreatic cancer; Pancreatic juice; Telomerase

Indexed keywords

TELOMERASE;

ADULT; AGED; ARTICLE; CANCER CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENZYME ACTIVITY; FEMALE; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MALE; PANCREAS; PANCREAS CANCER; PANCREAS DISEASE; PANCREAS JUICE; PRIORITY JOURNAL; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADENOCARCINOMA, PAPILLARY; AGED; BASE SEQUENCE; CARCINOMA, PANCREATIC DUCTAL; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; DNA PRIMERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC DISEASES; PANCREATIC JUICE; PANCREATIC NEOPLASMS; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 41149127401     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31815bc1d6     Document Type: Article

References (41)

1. Rosewicz S, Wiedenmann B. Pancreatic carcinoma. Lancet. 1997;349:485-489.
2. Bornman PC, Beckingham IJ. Pancreatic tumours. Br Med J. 2001;322:721-723.
3. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10-30.
4. Nakaizumi A, Tatsuta M, Uehara H, et al. Effectiveness of the cytologic examination of pure pancreatic juice in the diagnosis of early neoplasia of the pancreas. Cancer. 1995;76:750-757.
5. Uehara H, Nakaizumi A, Iishi H, et al. Cytologic examination of pancreatic juice differential diagnosis of benign and malignant mucin-producing tumors of the pancreas. Cancer. 1994;74:826-833.
6. Goodale RL, Gajl-Peczalaka K, Dressel T, et al. Cytologic studies for the diagnosis of pancreatic cancer. Cancer. 1981;47:1652-1655.
7. Mitchell ML, Carney CN. Cytologic criteria for the diagnosis of pancreatic carcinoma. Am J Clin Pathol. 1985;82:171-176.
8. Almoguera C, Shibata D, Forrester K, et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell. 1988;53:549-554.
9. Smit VTHBM, Boot AJM, Smits AMM, et al. KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res. 1988;16:7773-7782.
10. Tada M, Omata M, Kawai S, et al. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res. 1993;53:2472-2474.
11. Kondo H, Sugano K, Fukayama N, et al. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma. Cancer. 1994;73:1589-1594.
12. Uehara H, Nakaizumi A, Baba M, et al. Diagnosis of pancreatic cancer by K-ras point mutation and cytology of pancreatic juice. Am J Gastroenterol. 1996;91:1616-1621.
13. Furuya N, Kawa S, Akamatsu T, et al. Long-term follow-up of patients with chronic pancreatitis and K-ras gene mutation detected in pancreatic juice. Gastroenterology. 1997;113:593-598.
14. Boschman CR, Stryker S, Reddy JK, et al. Expression of p53 protein in precursor lesions and adenocarcinoma of human pancreas. Am J Pathol. 1994;45:1291-1295.
15. Ishimaru S, Itoh M, Hanada K, et al. Immunocytochemical detection of p53 protein from pancreatic duct brushings in patients with pancreatic carcinoma. Cancer. 1996;77:2233-2239.
16. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell. 1985;43:405-413.
17. Morin GB. The human telomere terminal transferase is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell. 1989;59:521-529.
18. Chadeneau C, Hay K, Hirte HW, et al. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res. 1995;55:2533-2536.
19. Tahara H, Nakanishi T, Kitamoto M, et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res. 1995;55:2734-2736.
20. Hiyama E, Yokoyama T, Tatsumoto N, et al. Telomerase activity in gastric cancer. Cancer Res. 1995;55:3258-3262.
21. Hiyama E, Kodama T, Shinbara K, et al. Telomerase activity is detected in pancreatic cancer but not in benign tumors. Cancer Res. 1997;57:326-331.
22. Tsutsumi M, Tsujiuchi T, Ishikawa O, et al. Increased telomerase activities in human pancreatic duct adenocarcinomas. Jpn J Cancer Res. 1997;88:971-976.
23. Iwao T, Hiyama E, Yokoyama T, et al. Telomerase activity for the preoperative diagnosis of pancreatic cancer. J Natl Cancer Inst. 1997; 89:1621-1623.
24. Suehara N, Mizumoto K, Tanaka M, et al. Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis. Clin Cancer Res. 1997;3:2479-2483.
25. Uehara H, Nakaizumi A, Tatsuta M, et al. Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations. Am J Gastroenterol. 1999;94:2513-2518.
26. Myung SJ, Kim MH, Kim YS, et al. Telomerase activity in pure pancreatic juice for the diagnosis of pancreatic cancer may be complementary to K-ras mutation. Gastrointest Endosc. 2000;51:708-713.
27. Inoue H, Tsuchida A, Kawasaki Y, et al. Preoperative diagnosis of intraductal papillary-mucinous tumors of the pancreas with attention to telomerase activity. Cancer. 2001;91:35-41.
28. Uemura K, Hiyama E, Murakami Y, et al. Comparative analysis of K-ras point mutation, telomerse activity, and p53 overexpression in pancreatic tumours. Oncol Rep. 2003;10:277-283.
29. Ohuchida K, Mizumoto K, Ishikawa N, et al. A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors. Cancer. 2004;101:2309-2317.
30. Ohuchida K, Mizumoto K, Ogura Y, et al. Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer. Clin Cancer Res. 2005;11:2285-2292.
31. Pearson AS, Chiao P, Zhang L, et al. The detection of telomerase activity in patients with adenocarcinoma of the pancreas by fine needle aspiration. Int J Oncol. 2000;17:381-385.
32. Mishra G, Zhao Y, Sweeney J, et al. Determination of qualitative telomerase activity as an adjunct to the diagnosis of pancreatic adenocarcinoma by EUS-guided fine-needle aspiration. Gastrointest Endosc. 2006;63:648-654.
33. Ohyashiki K, Ohyashiki JH, Nishimaki J, et al. Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay. Cancer Res. 1997;57:2100-2103.
34. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011-2015.
35. Counter CM, Gupta J, Harley CB, et al. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood. 1995;85:2315-2320.
36. Ohyashiki K, Yahata N, Ohyashiki JH, et al. A combination of semiquantative telomerase assay and in-cell telomerase activity measurement using exfoliated urothelial cells for the detection of urothelial neoplasia. Cancer. 1998;83:2554-2560.
37. Maruyama Y, Hanai H, Fujita M, et al. Telomere length and telomerase activity in carcinogenesis of the stomach. Jpn J Clin Oncol. 1997;27:216-220.
38. Miura N, Horikawa I, Nishimoto A, et al. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis. Cancer Genet Cytogenet. 1997;93:56-62.
39. Scates DK, Muir GH, Venitt S, et al. Detection of telomerase activity in human prostate: a diagnostic marker for prostatic cancer? Br J Urol. 1997;80:263-268.
40. Yanagisawa A, Ohtake K, Ohashi K, et al. Frequent c-K-ras oncogene in mucous cell hyperplasia of pancreas suffering from chronic inflammation. Cancer Res. 1993;53:953-956.
41. Tada M, Ohashi M, Shiratori Y, et al. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology. 1996;110:227-231.